Develops new influenza candidate vaccine strains for subsequent vaccine antigen manufacture
Job Summary
Develops new influenza candidate vaccine strains for subsequent vaccine antigen manufacture.
Designs and implements business experimental processes to enable product research and development.
CSL Seqirus is part of CSL. As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness.
Matching Summary
Develops new influenza candidate vaccine strains for subsequent vaccine antigen manufacture.